Why do Americans go to Mexico for stem cell therapy?
Americans go to Mexico for stem cell therapy because cultured donor-cell therapy is offered there, regulated by COFEPRIS, and in the U.S. it is largely limited to clinical trials. For a U.S. patient the trip is also short: Hospital Angeles, Tijuana is about 20 miles and 25 to 30 minutes from San Diego.
This page is not a sales pitch for our country. It is the country-level argument that has to be true before any clinic-level argument matters at all.
See the two regulators side by sideWho regulates stem cell therapy in Mexico?
COFEPRIS, the Comisión Federal para la Protección contra Riesgos Sanitarios, is Mexico's federal health regulator. Cell therapy in Mexico is regulated by COFEPRIS.
The reflex assumption is that “abroad” means “unregulated.” For Mexico, it isn't. Put the two regulators side by side and two of three variables mirror.
The third, access to cultured cell therapy, is where the two countries diverge. That single difference is why American patients with autoimmune, neurodegenerative, or refractory orthopedic conditions are flying south. Not because Mexico is unregulated. See The FDA line, in plain English.
- Materially similar: The manufacturing standard
- Materially similar: How side effects get reported
- Different: Access to cultured cell therapy
U.S. FDA: a drug pathway. Cultured donor cells are regulated as a drug. Outside an approved product, access is through a clinical trial or expanded access.
Mexico: offered in hospitals. Regulated by COFEPRIS, with documented informed consent.
How U.S. FDA and Mexico COFEPRIS handle each variable, row by row.
Read moreShow less
| U.S. FDA | Mexico COFEPRIS | |
|---|---|---|
| The manufacturing standard | Federal manufacturing standardcGMP, 21 CFR 210/211/600Inspected by FDA cGMP investigators. Form 483 issued for findings. | Federal manufacturing standardNOM-059-SSA1-2015Mexico's published good-manufacturing-practice standard for medicines. |
| How side effects get reported | Mandatory adverse-event reportingMedWatch + FAERSPublic-facing pharmacovigilance database. | Mandatory adverse-event reportingFarmacovigilancia + TecnovigilanciaPharmacovigilance plus a parallel medical-device track. |
How far is Tijuana from the United States?
For the typical U.S. patient, this is not a long-haul trip. You fly into San Diego International, a Celva driver meets you at the curb and drives you across the border.
The two countries share a 1,954-mile land border, Tijuana keeps the same clock as California, and Mexican hospitals have been treating American patients for decades. For Southern California patients, pickup is anywhere in the region, and most patients are home the same day. Hospital Angeles Tijuana is closer to most California, Arizona, and Nevada patients than the academic medical center in their own state.
Travel time from major U.S. metros to Hospital Angeles, Tijuana
- San Diego, CA SAN to Hospital Angeles 25 to 30 min from San Diego No airfare, a Celva driver
- Phoenix, AZ PHX to SAN ~1 hr 15 nonstop into SAN Short hop, round-trip economy
- Los Angeles, CA by car, via San Diego ~2 hr 30 by car No airfare, pickup anywhere in Southern California
- Dallas, TX DFW to SAN ~3 hr 15 nonstop into SAN Domestic-equivalent, round-trip economy
- Chicago, IL ORD to SAN ~4 hr 30 nonstop into SAN Domestic-equivalent, round-trip economy
- New York, NY JFK to SAN ~6 hr 15 nonstop into SAN Cross-country, round-trip economy
For the Western U.S. (California, Arizona, Nevada, Utah, New Mexico), Tijuana is commuting distance, faster than San Francisco to UCSF in traffic. Even from the East Coast, Tijuana is roughly equivalent to a domestic flight to Stanford, MD Anderson, or Cleveland Clinic. Panama and Cayman cost a full day each way.
How do you cross the border from San Diego to Tijuana?
There are two land crossings from San Diego to Tijuana. Your Celva driver uses San Ysidro in both directions, and you stay in the car.
San Ysidro
The busiest land crossing on Earth, on I-5 South, open 24 hours daily. You ride with a Celva driver: no pedestrian crossing, no transfers. Southbound is typically non-stop. Northbound uses the medical lane, with a pass requested through a Mexican government app, which keeps the crossing quick.
- Southbound Non-stop most days
- Northbound, medical lane The short line
- Northbound, public lane Can run to hours
This is why the medical lane matters.
The other way across: Otay Mesa, a less crowded alternative.
Read moreShow less
Otay Mesa Less crowded alternative
Commercial crossing, east of San Ysidro.
- Wait
- Varies, often shorter than San Ysidro
- Crossing
- No fee to cross, parking varies
- Mode
- Car or pedestrian
- Open
- 24 hours (vehicle)
Commercial-focused crossing roughly 6 miles east of San Ysidro. Faster on weekday mornings, less foot traffic, but adds 10 to 15 minutes of driving on the Mexican side to reach Zona Río. Good fallback when San Ysidro is backed up beyond 60 minutes.
Five things that have to be true of a country, and the evidence for Mexico
A destination has to clear five preconditions before it is a defensible choice for a U.S. patient. If any one of these fails, the rest of the argument doesn't matter. If all five hold, the next argument is at the clinic level, which is what Section 4, Why this clinic, is about.
-
2001
A federal regulator COFEPRIS, established 2001
Cell therapy in Mexico is regulated by COFEPRIS, the federal health regulator.
Source: COFEPRIS, gob.mx/cofepris -
28
Hospital infrastructure Angeles Health hospitals across Mexico
Hospital Angeles, Tijuana belongs to Angeles Health, a national private-hospital network.
Source: Angeles Health's own site, checked October 2026 -
1.2M
American patient flow U.S. patients cross a year
The approximate annual U.S. medical-tourist flow to Mexico, by one widely quoted estimate. Hospitals near the border have been adapted around this volume for decades: English by default, with billing, records, and discharge documents in U.S.-compatible formats.
Source: Patients Beyond Borders estimate -
U.S.
Physicians cross-trained in the U.S. Residencies and fellowships
Some Mexican specialists do residencies and fellowships at U.S. centers. Same journals, same protocols, same clinical language as your physician at home.
-
1 day
Same-day return From Southern California
Treatment is one day, and most patients are home the same day. You are not relocating. You are commuting to an unusual address.
An overnight only when your intake says so
These are facts about the country before they are facts about any one clinic. A country-level argument that depends on one good clinic is fragile. One that holds because of regulator framework, hospital infrastructure, physician training pipelines, and geography is durable. If our clinic disappeared tomorrow, the five would still be true; the patient could find another hospital-housed program regulated by COFEPRIS without leaving the country.
What happens after you go home?
The reasonable worry about cross-border care: you fly somewhere, get treated, fly home, then your U.S. doctor has no records and the foreign clinic isn't reachable. The answer is four phases, and two of them happen in the U.S.
-
United States
Before you travel
- A 15-minute call with a patient coordinator
- Your coordinator gathers whatever records you have; no MRI or bloodwork is required to start
- The physician team reviews
- A written answer and an itemized quote (a letter of medical necessity on request)
-
Mexico
Treatment day, one day on site
- You meet the physician before treatment
- A short check-in, treatment, and discharge the same day
- Treatment invoice with date, hospital, and treatment description
- U.S. follow-up calendar set on the same day
-
Bridge
The first month
- Follow-up call at 1 week, by phone or video
- Follow-up call at 1 month
- Calls come from your patient coordinator or aftercare specialist; a physician joins when needed
- Escalation pathway for any concerning finding
- Named human contact, not generic inbox
-
United States
At 3 and 6 months, then once a year
- Follow-up call at 3 months
- Follow-up call at 6 months
- Then a call once a year
- Lot records retained for 10+ years (regulator)
- Whether a second treatment makes sense is decided at your follow-up reviews
Patients picture a trip with a clinical event in the middle. The correct model is the inverse: a clinical relationship with a single treatment day attached. What follow-up looks like
Is it safe to go to Mexico for stem cell therapy?
That depends on which state and which facility. Four claims come up on every phone call. Open the one you have heard. The pattern is consistent: each is correct about the unaccredited strip-mall tier, the part U.S. press covers, and inaccurate about the accredited hospital tier where cell therapy operates.
“Mexican hospitals don't meet U.S. safety standards.”
True at the unaccredited tier, false at the accredited tier. Major Mexican private-hospital networks (Angeles Health, ABC) operate under the same national hospital-certification framework that audits leading Mexican academic centers, and many of their facilities have been independently surveyed against international hospital standards.
“Mexican doctors are trained to a lower standard.”
Some Hospital Angeles specialists hold U.S. residency or fellowship training. Cross-trained, not parallel-universe.
“If something goes wrong, you have no recourse.”
COFEPRIS adverse-event reporting is mandatory and parallel to FDA's. Hospital Angeles maintains malpractice coverage and a documented complaint pathway. Recourse exists; it just doesn't look identical to U.S. malpractice litigation.
“Mexico is unsafe: cartels, kidnappings, etc.”
A Celva patient is in a car with a Celva driver, then inside a hospital, then back across the border the same day.
The country isn't the variable. The facility is.
Each claim has a kernel of truth: it describes a tier of Mexican medicine that exists, just not the tier a responsible cell-therapy program operates in. A patient at Hospital Angeles, Tijuana, with named physicians, a laboratory regulated by COFEPRIS, and a discharge summary in English, is not in the Mexico of the press narrative. For the base rates across countries, read Is medical tourism safe?
The bottom line
For a U.S. patient considering cell therapy abroad, the variables that compound are proximity (hours, not days), a federal regulator (COFEPRIS), hospital infrastructure (a national private-hospital network), continuity of care, and return travel (most patients are home the same day). These are country-level facts, true before any clinic-level argument. The clinic argument, why Celva, is Section 4. This page is the precondition.